163 related articles for article (PubMed ID: 23365171)
1. Disseminated tuberculosis in a patient with antinuclear antibody-negative systemic lupus erythematosus: a rare association.
Kumar N; Aggarwal P; Dev N; Kumar G
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23365171
[TBL] [Abstract][Full Text] [Related]
2. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus.
Jolly M; Laumann AE; Shea CR; Utset TO
Lupus; 2004; 13(1):64-9. PubMed ID: 14870920
[TBL] [Abstract][Full Text] [Related]
3. Crossing of antinuclear antibodies and anti-leishmania antibodies.
Granel B; Serratrice J; Swiader L; Gambarelli F; Daniel L; Fossat C; Hesse-Bonérandi S; Pache X; Disdier P; Weiller PJ
Lupus; 2000; 9(7):548-50. PubMed ID: 11035423
[TBL] [Abstract][Full Text] [Related]
4. Juvenile systemic lupus erythematosus in Nigeria.
Adelowo OO; Olaosebikan BH; Animashaun BA; Akintayo RO
Lupus; 2017 Mar; 26(3):329-333. PubMed ID: 27771618
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report.
Arliny Y; Yanifitri DB; Utami WA; Geraldine S
F1000Res; 2023; 12():763. PubMed ID: 37965587
[No Abstract] [Full Text] [Related]
6. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.
Jallouli M; Saadoun D; Eymard B; Leroux G; Haroche J; Le Thi Huong D; De Gennes C; Chapelon C; Benveniste O; Wechsler B; Cacoub P; Amoura Z; Piette JC; Costedoat-Chalumeau N
J Neurol; 2012 Jul; 259(7):1290-7. PubMed ID: 22160434
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythmatosus - When to consider and management options.
Apostolopoulos D; Hoi AY
Aust Fam Physician; 2013 Oct; 42(10):696-700. PubMed ID: 24130970
[TBL] [Abstract][Full Text] [Related]
8. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers.
Monzavi SM; Alirezaei A; Shariati-Sarabi Z; Tavakol Afshari J; Mahmoudi M; Dormanesh B; Jahandoost F; Khoshdel AR; Etemad Rezaie A
Inflammopharmacology; 2018 Oct; 26(5):1175-1182. PubMed ID: 29987550
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibody-negative systemic lupus erythematosus in a case with pregnancy.
Xie Q; Liu Y; Yang N; Yin G
Rheumatol Int; 2012 Oct; 32(10):3273-6. PubMed ID: 20386913
[TBL] [Abstract][Full Text] [Related]
10. Acute acalculous cholecystitis as the initial manifestation of systemic lupus erythematous: A case report.
Lee J; Lee YJ; Kim Y
Medicine (Baltimore); 2021 Jun; 100(22):e26238. PubMed ID: 34087909
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
Izmirly PM; Kim MY; Llanos C; Le PU; Guerra MM; Askanase AD; Salmon JE; Buyon JP
Ann Rheum Dis; 2010 Oct; 69(10):1827-30. PubMed ID: 20447951
[TBL] [Abstract][Full Text] [Related]
12. [Systemic lupus erythematosus in children and adolescents].
Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
[TBL] [Abstract][Full Text] [Related]
13. The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al.
Major GA
Arthritis Rheum; 2011 Apr; 63(4):1157-8; author reply 1158. PubMed ID: 21452333
[No Abstract] [Full Text] [Related]
14. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies.
Hedgpeth MT; Boulware DW
Arthritis Rheum; 1988 Apr; 31(4):545-8. PubMed ID: 3258752
[TBL] [Abstract][Full Text] [Related]
15. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
Fujieda Y
Immunol Med; 2020 Dec; 43(4):135-141. PubMed ID: 32459601
[TBL] [Abstract][Full Text] [Related]
16. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
[TBL] [Abstract][Full Text] [Related]
17. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
[TBL] [Abstract][Full Text] [Related]
19. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C; Moroni G
Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
